More News

06 Mar 2020 Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
04 Mar 2020 Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology
04 Mar 2020 Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
04 Mar 2020 Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
02 Mar 2020 Gilead to Acquire Forty Seven for $4.9 Billion
29 Feb 2020 Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform
29 Feb 2020 Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
26 Feb 2020 Arcus Biosciences and Taiho Pharmaceutical Co., Ltd. Jointly Announce Taiho’s Exercise of Its Option for an Exclusive License to Zimberelimab (AB122) for Its Territories in Japan and Other Asian Countries
26 Feb 2020 Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
25 Feb 2020 Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Global Threat of Multi-drug Resistant Bacteria
25 Feb 2020 Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle®-based Immuno-oncology Therapies
24 Feb 2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
20 Feb 2020 Tocagen and Forte Biosciences Announce Merger
20 Feb 2020 Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
20 Feb 2020 Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
19 Feb 2020 Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
12 Feb 2020 OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico
10 Feb 2020 Blue Water Vaccines Licenses Patent Rights for Streptococcus Pneumoniae Vaccine Development from St. Jude Children's Research Hospital
06 Feb 2020 Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in Oncology
05 Feb 2020 Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments
04 Feb 2020 SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
04 Feb 2020 EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion
03 Feb 2020 AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders
03 Feb 2020 IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases
29 Jan 2020 Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up